Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.
Federal public service unions say the government's plan to get employees back to the office is confusing, disjointed and jeopardizing health and safety.
Ottawa biotech startup has raised $7.5 million in fresh funding as it looks to capitalize what it says is the continued need for "a decentralized, laboratory-quality" test kit.
Treasury Board president Mona Fortier gave the green light Monday for federal departments and agencies to begin bringing public servants back to the office.
Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Ottawa company says it plans to begin shipping the device “immediately” to federal and provincial governments as well as commercial customers.
After facing months of delays, Ottawa biotech firm is hoping its rapid testing device is poised to clear the final hurdle before it can go to market.
Company says it hopes to get Health Canada’s approval to market the test “in the coming weeks.”
Ottawa firm says it has applied to Health Canada to begin clinical trials on a fix for its rapid COVID-19 testing device after the agency had concerns about the test’s effectiveness.
An Ottawa-based biotech firm says Health Canada has given it the go-ahead to start shipping its rapid COVID-19 testing technology.